Back to resultsElectrogastrography (EGC) in Premature Infants With Feeding Intolerance
Primary Purpose
Infant, Newborn, Diseases
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
metoclopramide
Sponsored by
About this trial
This is an interventional treatment trial for Infant, Newborn, Diseases focused on measuring Feeding intolerance, Infant, premature
Eligibility Criteria
Inclusion: Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Sites / Locations
- Children's Hospital of Philadelphia
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00008736
First Posted
January 16, 2001
Last Updated
June 23, 2005
Sponsor
National Center for Research Resources (NCRR)
Collaborators
Children's Hospital of Philadelphia
1. Study Identification
Unique Protocol Identification Number
NCT00008736
Brief Title
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
Official Title
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide
Study Type
Interventional
2. Study Status
Record Verification Date
December 2003
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Center for Research Resources (NCRR)
Collaborators
Children's Hospital of Philadelphia
4. Oversight
5. Study Description
Brief Summary
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infant, Newborn, Diseases
Keywords
Feeding intolerance, Infant, premature
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Allocation
Non-Randomized
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
metoclopramide
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Minute
Maximum Age & Unit of Time
1 Month
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion:
Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Facility Information:
Facility Name
Children's Hospital of Philadelphia
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
We'll reach out to this number within 24 hrs